封面
市場調查報告書
商品編碼
2049425

口蹄疫疫苗市場分析:按動物類型、疫苗類型、通路和地區分類(2026-2034 年)

Foot and Mouth Disease Vaccine Market Report by Animal Type, Vaccine Type, Distribution Channel, and Region 2026-2034

出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年,全球口蹄疫疫苗市場規模達24.134億美元。展望未來,IMARC Group預測,從2026年到2034年,該市場將以6.24%的複合年成長率成長,到2034年達到42.283億美元。

口蹄疫是由一種跨國傳染性病毒引起的,主要感染偶蹄類動物。它主要影響家畜,如水牛、豬、綿羊和山羊,以及一些野生動物,如鹿、野牛、駱駝和羚羊。口蹄疫病毒(FMDV)有七種免疫學上不同的血清型:O、A、C、SAT1、SAT2、SAT3 和 Asia 1。這種病毒性疾病會導致動物出現通用症狀,包括嘴唇和舌頭上水痘、發燒、流涎過多、食慾不振以及肉和奶產量下降。目前使用多種以氫氧化鋁、皂素和油劑為基礎的疫苗來預防口蹄疫感染。

口蹄疫的高發生率及其對國際動物產品貿易的社會經濟影響,正在推動口蹄疫疫苗市場的成長。肉類加工業的擴張和乳製品消費量的成長也促進了對口蹄疫疫苗的需求。此外,對高品質、無病畜肉類的需求不斷成長,進一步推動了市場成長。同時,強制性牛標準的推出也促使各國大量採購疫苗以控制口蹄疫疫情。此外,世界各國政府正在實施多項宣傳計劃,以保護瀕危野生動物物種(如野牛和羚羊)免受口蹄疫的侵害。全球化以及已開發市場和開發中國家中市場牲畜數量的成長,也促進了口蹄疫疫苗市場的成長。最後,為牲畜提供安全醫療服務的獸醫中心數量的增加,也對市場成長產生了積極影響。

本報告解答的主要問題

  • 全球口蹄疫疫苗市場的歷史發展趨勢是什麼?未來幾年預計會如何發展?
  • 新冠疫情對全球口蹄疫疫苗市場產生了哪些影響?
  • 主要區域市場有哪些?
  • 市場是如何依動物種類細分的?
  • 疫苗市場如何依疫苗類型細分?
  • 市場如何依分銷管道細分?
  • 該產業價值鏈包含哪些不同階段?
  • 該行業的主要促進因素和挑戰是什麼?
  • 全球口蹄疫疫苗市場的結構是怎麼樣的?主要參與者有哪些?
  • 這個行業的競爭有多激烈?

目錄

第1章:序言

第2章:分析的範圍與方法

  • 分析目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 分析方法

第3章執行摘要

第4章:引言

第5章:全球口蹄疫疫苗市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔:依動物類型

  • 綿羊/山羊
  • 其他

第7章 市場區隔:依疫苗類型

  • 傳統疫苗
    • 油性疫苗
    • 氫氧化鋁/皂素疫苗
  • 緊急疫苗

第8章 市場區隔:按分銷管道

  • 政府機構
  • 批發商/藥房
  • 私人動物醫院
  • 其他

第9章 市場區隔:依地區分類

  • 亞太地區
    • 中國
    • 印度
    • 孟加拉
    • 越南
    • 韓國
    • 其他
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他
  • 中東和非洲
    • 奈及利亞
    • 衣索比亞
    • 伊朗
    • 阿爾及利亞
    • 其他
  • 歐洲
    • 土耳其
    • 喬治亞
    • 亞美尼亞

第10章 SWOT 分析

第11章:價值鏈分析

第12章:波特五力分析

第13章:價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Paramount Agrovet Pvt. Ltd.
    • Bayer AG
    • Biogenesis Bago
    • Boehringer Ingelheim International GmbH
    • Brilliant Bio Pharma Private Limited
    • China Animal Husbandry Group
    • FGBI "Federal Center for Animal Health"
    • Indian Immunologicals Ltd.
    • Limor de Colombia
    • Merck & Co. Inc
    • Vecol SA
    • Vetal Animal Health Products Inc.
Product Code: SR112026A2871

The global foot and mouth disease (FMD) vaccine market size reached USD 2,413.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 4,228.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.24% during 2026-2034.

The foot and mouth disease (FMD) occurs due to a transboundary, contagious virus that infects cloven-hoofed animals. It primarily affects cattle, such as buffaloes, pigs, sheep, goats, etc., and a few wildlife species, including deer, bison, camelid, antelope, etc. The FMD virus (FMDV) has seven immunologically distinct serotypes, namely O, A, C, SAT1, SAT2, SAT3, and Asia 1. This viral disease exhibits common symptoms in animals, such as blisters on lips and tongue, fever, excessive salivation, anorexia, low meat and milk productivity, etc. Several vaccines, based on aluminum hydroxide , saponin, and oil formulations, are used against FMD contraction.

The high prevalence of FMD along with its socio-economic impact on the international trade of animal products is driving the FMD vaccine market. The growing meat processing industry and the increasing consumption of dairy products are also fueling the need for FMD vaccines. Additionally, the rising demand for high-grade and disease-free meat supply from livestock is further augmenting the market growth. Apart from this, the implementation of mandatory norms regarding cattle rearing is leading to the bulk purchase of vaccines to control FMD outbreaks. Furthermore, government bodies across the globe are also introducing several awareness programs for protecting endangered wildlife species, such as bison and antelope, against FMD. Rising globalization along with the growing livestock population across both developed and developing markets is also driving the market for FMD vaccines. Furthermore, the increasing presence of veterinary centers providing safe healthcare practices for livestock is also creating a positive impact on the market growth.

KEY MARKET SEGMENTATION:

Breakup by Animal Type:

  • Cattle
  • Pig
  • Sheep and Goat
  • Others

Breakup by Vaccine Type:

  • Conventional Vaccines
    • Oil-Based Vaccines
    • Aluminum hydroxide/saponin-based Vaccines
  • Emergency Vaccines

Breakup by Distribution Channel:

  • Government Organizations
  • Distributors/Pharmacies
  • Private Vet
  • Others

Breakup by Region:

  • Asia Pacific
    • China
    • India
    • Bangladesh
    • Vietnam
    • Korea
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Others
  • Middle East and Africa
    • Nigeria
    • Ethiopia
    • Iran
    • Algeria
    • Others
  • Europe
    • Turkey
    • Georgia
    • Armenia

COMPETITIVE LANDSCAPE :

The competitive landscape of the industry has also been examined with some of the key players being Paramount Agrovet Pvt. Ltd., Bayer AG, Biogenesis Bago, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, China Animal Husbandry Group, FGBI "Federal Center for Animal Health", Indian Immunologicals Ltd., Limor De Colombia, Merck & Co., Inc., Vecol S.A and Vetal Animal Health Products Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global foot and mouth disease (FMD) vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global foot and mouth disease (FMD) vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the animal type?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global foot and mouth disease (FMD) vaccine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Foot and Mouth Disease (FMD) Vaccine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Cattle
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pig
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Sheep and Goat
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Vaccine Type

  • 7.1 Conventional Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Oil-Based Vaccines
      • 7.1.2.1 Market Trends
      • 7.1.2.2 Market Forecast
    • 7.1.3 Aluminum hydroxide/saponin-based Vaccines
      • 7.1.3.1 Market Trends
      • 7.1.3.2 Market Forecast
    • 7.1.4 Market Forecast
  • 7.2 Emergency Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Government Organizations
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Distributors/Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Private Vet
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Asia Pacific
    • 9.1.1 China
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 India
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Bangladesh
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Vietnam
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Korea
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Latin America
    • 9.2.1 Brazil
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Argentina
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Others
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
  • 9.3 Middle East and Africa
    • 9.3.1 Nigeria
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Ethiopia
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 Iran
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Algeria
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Others
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
  • 9.4 Europe
    • 9.4.1 Turkey
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Georgia
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Armenia
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Paramount Agrovet Pvt. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biogenesis Bago
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Brilliant Bio Pharma Private Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 China Animal Husbandry Group
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 FGBI "Federal Center for Animal Health"
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Indian Immunologicals Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Limor de Colombia
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Merck & Co. Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Vecol S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Vetal Animal Health Products Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Major Drivers and Challenges
  • Figure 2: Global: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Animal Type (in %), 2025
  • Figure 4: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Vaccine Type (in %), 2025
  • Figure 5: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Distribution Channel (in %), 2025
  • Figure 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 8: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Foot and Mouth Disease (FMD) Vaccine (Cattle) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Foot and Mouth Disease (FMD) Vaccine (Pig) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Foot and Mouth Disease (FMD) Vaccine (Sheep and Goat) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Foot and Mouth Disease (FMD) Vaccine (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Foot and Mouth Disease (FMD) Vaccine (Oil-Based Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Foot and Mouth Disease (FMD) Vaccine (Aluminum hydroxide/saponin-based Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Foot and Mouth Disease (FMD) Vaccine (Conventional Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Foot and Mouth Disease (FMD) Vaccine (Emergency Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Foot and Mouth Disease (FMD) Vaccine (Government Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Foot and Mouth Disease (FMD) Vaccine (Distributors/Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Foot and Mouth Disease (FMD) Vaccine (Private Vet) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Foot and Mouth Disease (FMD) Vaccine (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: China: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: India: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: India: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Bangladesh: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Vietnam: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Korea: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Korea: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Latin America: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Brazil: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Brazil: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Argentina: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Argentina: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Latin America: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Nigeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Ethiopia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Iran: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Iran: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Algeria: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Algeria: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Europe: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Turkey: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Turkey: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Georgia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Georgia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Armenia: Foot and Mouth Disease (FMD) Vaccine Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Armenia: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Europe: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Global: Foot and Mouth Disease (FMD) Vaccine Industry: SWOT Analysis
  • Figure 75: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Value Chain Analysis
  • Figure 76: Global: Foot and Mouth Disease (FMD) Vaccine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Animal Type (in Million USD), 2026-2034
  • Table 3: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Vaccine Type (in Million USD), 2026-2034
  • Table 4: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Foot and Mouth Disease (FMD) Vaccine Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Foot and Mouth Disease (FMD) Vaccine Market: Competitive Structure
  • Table 7: Global: Foot and Mouth Disease (FMD) Vaccine Market: Key Players